BioNote, Inc. (KRX:377740)

BioNote Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	551,405	480,684	433,228	874,096	-	-
Market Cap Growth	17.62%	10.95%	-50.44%	-	-	-
Enterprise Value	204,929	83,431	16,432	174,842	-	-
Last Close Price	5440.00	4518.73	3891.81	7866.13	-	-
PE Ratio	4.69	8.70	-	2.84	-	-
PS Ratio	4.79	4.68	4.81	1.82	-	-
PB Ratio	0.32	0.29	0.28	0.55	-	-
P/TBV Ratio	0.32	0.30	0.28	0.55	-	-
P/FCF Ratio	26.69	10.13	-	4.23	-	-
P/OCF Ratio	17.45	8.30	-	3.51	-	-
EV/Sales Ratio	1.78	0.81	0.18	0.37	-	-
EV/EBITDA Ratio	1.53	4.09	-	0.58	-	-
EV/EBIT Ratio	1.63	6.83	-	0.59	-	-
EV/FCF Ratio	9.92	1.76	-	0.85	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.13	0.19	-	0.00	0.00	0.00
Debt / FCF Ratio	0.17	0.08	-	0.01	0.00	0.00
Net Debt / Equity Ratio	-0.20	-0.24	-0.25	-0.45	-0.38	-0.32
Net Debt / EBITDA Ratio	-12.72	-19.68	10.14	-2.39	-1.03	-0.36
Net Debt / FCF Ratio	-16.77	-8.46	48.46	-3.48	-1.00	-0.95
Asset Turnover	0.07	0.06	0.05	0.30	0.53	1.28
Inventory Turnover	1.96	1.86	1.86	1.94	1.87	1.71
Quick Ratio	33.06	18.20	39.35	14.94	4.84	2.80
Current Ratio	35.92	19.69	42.26	16.66	5.42	3.12
Return on Equity (ROE)	7.15%	3.46%	-1.30%	21.43%	70.80%	141.00%
Return on Assets (ROA)	0.68%	0.46%	-1.76%	11.38%	25.01%	70.87%
Return on Invested Capital (ROIC)	1.21%	0.77%	-4.62%	26.34%	59.77%	154.08%
Return on Capital Employed (ROCE)	1.10%	0.70%	-3.00%	17.30%	34.20%	83.30%
Earnings Yield	21.34%	11.50%	-4.73%	35.21%	-	-
FCF Yield	3.75%	9.87%	-1.88%	23.66%	-	-
Dividend Yield	3.68%	4.43%	-	-	-	-
Payout Ratio	17.23%	36.94%	-	16.23%	7.38%	-
Buyback Yield / Dilution	0.77%	0.08%	-8.16%	-0.64%	-0.14%	-11.08%
Total Shareholder Return	4.50%	4.51%	-8.16%	-0.64%	-0.14%	-11.08%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.